366 related articles for article (PubMed ID: 24953723)
41. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children.
Mellins CA; Brackis-Cott E; Dolezal C; Abrams EJ
Pediatr Infect Dis J; 2004 Nov; 23(11):1035-41. PubMed ID: 15545859
[TBL] [Abstract][Full Text] [Related]
42. Factors associated with adherence to antiretroviral therapy among HIV infected children in Kabale district, Uganda: a cross sectional study.
Wadunde I; Tuhebwe D; Ediau M; Okure G; Mpimbaza A; Wanyenze RK
BMC Res Notes; 2018 Jul; 11(1):466. PubMed ID: 30001748
[TBL] [Abstract][Full Text] [Related]
43. Usefulness of pharmacy dispensing records in the evaluation of adherence to antiretroviral therapy in Brazilian children and adolescents.
Ernesto AS; Lemos RM; Huehara MI; Morcillo AM; Dos Santos Vilela MM; Silva MT
Braz J Infect Dis; 2012; 16(4):315-20. PubMed ID: 22846117
[TBL] [Abstract][Full Text] [Related]
44. Optimal antiretroviral therapy adherence as evaluated by CASE index score tool is associated with virological suppression in HIV-infected adults in Dakar, Senegal.
Byabene AK; Fortes-Déguénonvo L; Niang K; Manga MN; Bulabula ANH; Nachega JB; Seydi M
Trop Med Int Health; 2017 Jun; 22(6):776-782. PubMed ID: 28407436
[TBL] [Abstract][Full Text] [Related]
45. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
46. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.
Williams PL; Storm D; Montepiedra G; Nichols S; Kammerer B; Sirois PA; Farley J; Malee K;
Pediatrics; 2006 Dec; 118(6):e1745-57. PubMed ID: 17101712
[TBL] [Abstract][Full Text] [Related]
47. Disease disclosure, treatment adherence, and behavioural profile in a cohort of vertically acquired HIV-infected adolescents. NeuroCoRISpeS study.
Medin G; García-Navarro C; Navarro Gomez M; Ramos Amador JT; Mellado MJ; Jimenez S; Muñoz-Fernández MA; Rojo Conejo P; Saavedra J; García Hortelano M; Guillén S; González-Tomé MI
AIDS Care; 2016; 28(1):124-30. PubMed ID: 26307530
[TBL] [Abstract][Full Text] [Related]
48. Non-persistence to antiretroviral therapy among adults receiving HIV medical care in the United States.
Nyaku M; Beer L; Shu F
AIDS Care; 2019 May; 31(5):599-608. PubMed ID: 30309269
[TBL] [Abstract][Full Text] [Related]
49. [Clinical evaluation of adherence to antiretroviral therapy in adolescents infected by HIV since infancy].
Vanthournout B; Van Der Kelen E; Elate D; Goetghebuer T; Hainaut M; Levy J
Arch Pediatr; 2013 Apr; 20(4):348-55. PubMed ID: 23466406
[TBL] [Abstract][Full Text] [Related]
50. Measuring adherence to antiretroviral therapy in children and adolescents in western Kenya.
Vreeman RC; Nyandiko WM; Liu H; Tu W; Scanlon ML; Slaven JE; Ayaya SO; Inui TS
J Int AIDS Soc; 2014; 17(1):19227. PubMed ID: 25427633
[TBL] [Abstract][Full Text] [Related]
51. Determinants of nonsuppression of HIV viral load among children receiving antiretroviral therapy in the Simiyu region: a cross-sectional study.
Mageda K; Kulemba K; Olomi W; Kapologwe N; Katalambula L; Petrucka P
AIDS Res Ther; 2023 Apr; 20(1):22. PubMed ID: 37055786
[TBL] [Abstract][Full Text] [Related]
52. Comprehensive evaluation of caregiver-reported antiretroviral therapy adherence for HIV-infected children.
Vreeman RC; Nyandiko WM; Liu H; Tu W; Scanlon ML; Slaven JE; Ayaya SO; Inui TS
AIDS Behav; 2015 Apr; 19(4):626-34. PubMed ID: 25613594
[TBL] [Abstract][Full Text] [Related]
53. Virological suppression in children and adolescents is not influenced by genotyping, but depends on optimal adherence to antiretroviral therapy.
Abreu JC; Vaz SN; Netto EM; Brites C
Braz J Infect Dis; 2017; 21(3):219-225. PubMed ID: 28253476
[TBL] [Abstract][Full Text] [Related]
54. Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report.
Buchanan AL; Montepiedra G; Sirois PA; Kammerer B; Garvie PA; Storm DS; Nichols SL
Pediatrics; 2012 May; 129(5):e1244-51. PubMed ID: 22508915
[TBL] [Abstract][Full Text] [Related]
55. HIV treatment-related knowledge and self-efficacy among caregivers of HIV-infected children.
Nicholson O; Mellins C; Dolezal C; Brackis-Cott E; Abrams EJ
Patient Educ Couns; 2006 Jun; 61(3):405-10. PubMed ID: 16246515
[TBL] [Abstract][Full Text] [Related]
56. The importance of caregivers in the outcome of pediatric HIV management, Mombasa, Kenya.
Sivapalasingam S; Mendillo M; Ahmed A; Mwamzuka M; Said S; Marshed F; Luhar Abdulaziz F; Fajans M; Holzman R
AIDS Care; 2014 Apr; 26(4):425-33. PubMed ID: 24090313
[TBL] [Abstract][Full Text] [Related]
57. Effect of caregivers' depression and alcohol use on child antiretroviral adherence in South Africa.
Jaspan HB; Mueller AD; Myer L; Bekker LG; Orrell C
AIDS Patient Care STDS; 2011 Oct; 25(10):595-600. PubMed ID: 21470047
[TBL] [Abstract][Full Text] [Related]
58. The Longitudinal Effects of Non-injection Substance Use on Sustained HIV Viral Load Undetectability Among MSM and Heterosexual Men in Brazil and Thailand: The Role of ART Adherence and Depressive Symptoms (HPTN 063).
Tsuyuki K; Shoptaw SJ; Ransome Y; Chau G; Rodriguez-Diaz CE; Friedman RK; Srithanaviboonchai K; Li S; Mimiaga MJ; Mayer KH; Safren SA
AIDS Behav; 2019 Mar; 23(3):649-660. PubMed ID: 30725397
[TBL] [Abstract][Full Text] [Related]
59. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents.
Martin S; Elliott-DeSorbo DK; Wolters PL; Toledo-Tamula MA; Roby G; Zeichner S; Wood LV
Pediatr Infect Dis J; 2007 Jan; 26(1):61-7. PubMed ID: 17195708
[TBL] [Abstract][Full Text] [Related]
60. Adherence to antiretroviral drug therapy in children with HIV/AIDS in Jamaica.
White YR; Pierre RB; Steel-Duncan J; Palmer P; Evans-Gilbert T; Moore J; Rodriguez B; Christie CD;
West Indian Med J; 2008 Jun; 57(3):231-7. PubMed ID: 19583121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
